Comparison of rATG with hATG: matched pair analysis
| . | rATG, n = 35 (%) . | hATG, n = 105 (%) . |
|---|---|---|
| Age, y | ||
| 0-20 | 4 (11%) | 12 (11%) |
| 21-60 | 24 (69%) | 72 (69%) |
| > 60 | 7 (20%) | 21 (20%) |
| Disease severity | ||
| ≤ 0.5 × 109/L neutrophils | 26 (74%) | 78 (74%) |
| > 0.5 × 109/L neutrophils | 9 (26%) | 27 (26%) |
| VSAA | 6 (17%) | 26% |
| Median interval diagnosis to treatment, d | 53 | 75 (P = 0.3) |
| Median follow-up, d (range) | 285 (6-781); P < .00001 | 1241 (21-4802) |
| . | rATG, n = 35 (%) . | hATG, n = 105 (%) . |
|---|---|---|
| Age, y | ||
| 0-20 | 4 (11%) | 12 (11%) |
| 21-60 | 24 (69%) | 72 (69%) |
| > 60 | 7 (20%) | 21 (20%) |
| Disease severity | ||
| ≤ 0.5 × 109/L neutrophils | 26 (74%) | 78 (74%) |
| > 0.5 × 109/L neutrophils | 9 (26%) | 27 (26%) |
| VSAA | 6 (17%) | 26% |
| Median interval diagnosis to treatment, d | 53 | 75 (P = 0.3) |
| Median follow-up, d (range) | 285 (6-781); P < .00001 | 1241 (21-4802) |
VSAA indicates very severe AA.